Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Parental Medical History on the Prevalence of Cerebrovascular Diseases in Their Children in an Iran Ian Population Publisher



Khosravi A1 ; Behjati M2 ; Dianatkhah M3 ; Noori F3 ; Nejati M4 ; Sarrafzadegan N3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran
  3. 3. Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Science, Isfahan, Iran
  4. 4. Anatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran

Source: Basic and Clinical Neuroscience Published:2018


Abstract

Introduction: still a controversial issue, family history is known as a risk factor for the development of Cerebrovascular Diseases (CVD). In this study, we aimed to evaluate the relationship between parental history and risk of CVD in their offspring in Iranian population. Methods: Isfahan Cohort Study (ICS) included total 6504 healthy participants which were randomly selected through a two-stage cluster sampling method from three districts. The participants were followed prospectively for 10 years. The diagnosis of CVD were confirmed by expert panelist. Clinically validated history of CVD was established for definition of parental history of CVD. Types of history were categorized into paternal, maternal, both parents, and no history. Results: The prevalence of CVD is generally higher among female offspring compared with male ones (P<0.001). The relative risk of CVD with maternal history was not significant (95%CI=0.95-2.29). By adjusted model analysis, history of CVD in both parents affected the risk of CVD in their male children (RR=2.13, P=0.033, 95%CI). By crude model analysis, maternal history of CVD (P=0.047), history of CVD in both parents (P=0.032), and maternal history of hypertension (P=0.005) were determined as risk factors of CVD in offspring. Indeed, the mean age of CVD in offspring decreases based on this order: history of hypertension in parents, paternal history of CVD in both parents, maternal history of CVD, and no history (P<0.001). Conclusion: Early and regular screening for CVD development is necessary in female offspring of the families with the present history of CVD from maternal side. This group are at risk and should be considered as the target group for screening and taking preventive measures. © 2018 Iran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models, Global Heart (2021)
2. A 10-Year Isfahan Cohort on Cardiovascular Disease As a Master Plan for a Multi-Generation Non-Communicable Disease Longitudinal Study: Methodology and Challenges, Journal of Human Hypertension (2019)
3. Pars Risk Charts: A 10-Year Study of Risk Assessment for Cardiovascular Diseases in Eastern Mediterranean Region, PLoS ONE (2017)
4. Long-Term Exposure to Pm2.5 and Cardiovascular Disease Incidence and Mortality in an Eastern Mediterranean Country: Findings Based on a 15-Year Cohort Study, Environmental Health: A Global Access Science Source (2021)
5. Tea and Coffee Consumption and the 15-Year Risk of Cardiovascular Events: The Isfahan Cohort Study (Ics), Nutrition Journal (2025)
6. Occupational Categories and Cardiovascular Diseases Incidences: A Cohort Study in Iranian Population, Journal of Preventive Medicine and Hygiene (2020)
7. The Association Between the Serum 25-Hydroxyvitamin D Level and Cardiovascular Events in Individuals With and Without Metabolic Syndrome, ARYA Atherosclerosis (2018)
8. Major Congenital Anomalies and Associated Risk Factors in Isfahan Province, Iran, 2014-2015, Journal of Isfahan Medical School (2019)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (27)
Masoumeh Sadeghi (20)
Other Related Docs
9. Cerebral Vein and Dural Sinus Thrombosis in Adults in Isfahan, Iran: Frequency and Seasonal Variation, Acta Neurologica Scandinavica (2008)
10. Persian Registry of Cardiovascular Disease (Prove): Design and Methodology, ARYA Atherosclerosis (2017)
11. Public Stroke Knowledge, Awareness, and Response to Acute Stroke in Isfahan Iran: What Is Less or Misinterpreted in Developing Countries, Journal of Stroke and Cerebrovascular Diseases (2021)
12. Dietary Patterns and Mortality From Cardiovascular Disease: Isfahan Cohort Study, European Journal of Clinical Nutrition (2017)
13. Secular Trends in Cardiovascular Mortality in Iran, With Special Reference to Isfahan, Acta Cardiologica (1999)
14. Pathways Leading to Prevention of Fatal and Non-Fatal Cardiovascular Disease: An Interaction Model on 15 Years Population-Based Cohort Study, Lipids in Health and Disease (2020)
15. Maternal or Paternal History: Which One Plays More Important Role in Developing Hypertension?, ARYA Atherosclerosis (2022)
16. Is Prehypertension a Risk Factors for Cardiovascular Diseases Among Iranian Women?, Journal of Research in Medical Sciences (2012)
17. Cardiovascular Disease Burden in the North Africa and Middle East Region: An Analysis of the Global Burden of Disease Study 1990–2021, BMC Cardiovascular Disorders (2024)
18. Ethnic Differences in the Lifestyle Behaviors and Premature Coronary Artery Disease: A Multi-Center Study, BMC Cardiovascular Disorders (2023)
19. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study, Metabolic Syndrome and Related Disorders (2019)
20. Heart Rate and Cardiovascular Events: A Nested Case-Control in Isfahan Cohort Study, Archives of Iranian Medicine (2014)
21. Risk Factors of Congenital Heart Diseases: A Hospital-Based Case-Control Study in Isfahan, Iran, ARYA Atherosclerosis (2020)
22. Is Family History of Premature Cardiovascular Diseases Appropriate for Detection of Dyslipidemic Children in Population-Based Preventive Medicine Programs? Caspian Study, Pediatric Cardiology (2006)
23. Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention, Archives of Iranian Medicine (2019)
24. Incidence of Cardiovascular Diseases in an Iranian Population: The Isfahan Cohort Study, Archives of Iranian Medicine (2013)
25. Prevalence, Awareness, Treatment, Control, and Risk Factors of Hypertension Among Adults: A Cross-Sectional Study in Iran, Epidemiology and Health (2018)
26. Methods of Sampling and Sample Size Determination of a Comprehensive Integrated Community-Based Interventional Trial: Isfahan Healthy Heart Program, ARYA Atherosclerosis (2018)
27. Socioeconomic Status and Incident Cardiovascular Disease in a Developing Country: Findings From the Isfahan Cohort Study (Ics), International Journal of Public Health (2012)
28. Pre-Hypertension, Pre-Diabetes or Both: Which Is Best at Predicting Cardiovascular Events in the Long Term?, Journal of Human Hypertension (2017)
29. Prevalence of Dyslipidemia in Iranian Children and Adolescents: A Systematic Review, Journal of Research in Medical Sciences (2015)
30. Cardiovascular Mortality in a Western Asian Country: Results From the Iran Cohort Consortium, BMJ Open (2018)
31. Does the Impact of Metabolic Syndrome on Cardiovascular Events Vary by Using Different Definitions? Chronic Disease Epidemiology, BMC Public Health (2015)
32. Low-Density Lipoprotein Cholesterol and Metabolic Syndrome in an Iranian High-Risk Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)
33. Association of Anthropometric Indices With Cardiovascular Disease Risk Factors Among Children and Adolescents: Caspian Study, International Journal of Cardiology (2007)
34. A Systematic Review and Meta-Analysis on Screening Lipid Disorders in the Pediatric Age Group, Journal of Research in Medical Sciences (2015)
35. Prevalence and Trends of Vitamin D Deficiency Among Iranian Adults: A Longitudinal Study From 2001–2013, Journal of Nutritional Science and Vitaminology (2017)
36. Effects of Early Repolarization on Electrocardiography and Long-Term Cardiovascular Outcomes: A 15-Year Population-Based Cohort Study, Journal of Tehran University Heart Center (2022)
37. The Influence of Gender and Place of Residence on Cardiovascular Diseases and Their Risk Factors. the Isfahan Cohort Study, Saudi Medical Journal (2012)
38. Comparison Between European and Iranian Cutoff Points of Triglyceride/High-Density Lipoprotein Cholesterol Concentrations in Predicting Cardiovascular Disease Outcomes, Journal of Clinical Lipidology (2016)
39. Cardiovascular Risk Factors in Iranian Adults According to Educational Levels: Isfahan Healthy Heart Program, Asia-Pacific Journal of Public Health (2005)
40. Risk and Age of Cardiovascular Event in Women With Metabolic Syndrome: Menopause Age in Focus, Metabolic Syndrome and Related Disorders (2018)
41. Risk and Protective Factors Related to Having a Child With Congenital Heart Diseases (Chd): A Case-Control Study in Iran, Frontiers in Pediatrics (2023)
42. The Prospective Epidemiological Research Studies in Iran (Persian) Birth Cohort Protocol: Rationale, Design and Methodology, Longitudinal and Life Course Studies (2021)
43. Transition in Public Knowledge of Risk Factors of Cardiovascular Disease in an Iranian General Population: A Latent Transition Analysis (Lta) on a Longitudinal Large Community-Based Educational Prevention Program, ARYA Atherosclerosis (2016)